Skip to main content

Table 7 Relation between patient characteristics and steroid receptor status by immunocytochemistry and dextran-coated charcoal [159]

From: Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

   Estrogen receptor positive Progesterone receptor positive
Parameter n (%) ICC (%) DCC (%) ICC (%) DCC (%)
Axillary node status (n = 241)      
   N0 120 (49.8) 88 (73.3) 98 (81.7) 83 (69.1) 93 (77.5)
   N+ 121 (50.2) 75 (62.0) 89 (73.6) 75 (61.9) 94 (77.7)
Tumor size (cm) (n = 229a)      
   <2 86 (37.6) 59 (68.6) 69 (80.2) 60 (69.8) 69 (80.2)
   2-5 128 (55.9) 88 (68.8) 101 (78.9) 84 (65.6) 100 (78.1)
   >5 15 (6.6) 8 (53.3) 9 (60.0) 8 (53.3) 9 (60.0)
Tumor histology (n = 241)      
   Invasive ductal 171 (71.0) 120 (70.2) 136 (79.5) 119 (69.6) 136 (79.5)
   Lobular 38 (15.8) 26 (68.4) 31 (81.6) 22 (57.9) 30 (78.9)
   Otherb 32 (13.2) 17 (53.1) 20 (62.5) 17 (53.1) 21 (65.6)
Tumor grade (n = 217)c      
   1 + 2 142 (65.4) 106 (74.7) 118 (83.1) 104 (73.2) 119 (83.8)
   3 75 (34.6) 41 (54.7) 52 (69.3) 36 (48.0) 53 (70.7)
Patient age (y) (n = 241)      
   ≤50 63 (26.1) 26 (41.3) 42 (66.7) 45 (71.4) 54 (85.7)
   >50 178 (73.9) 137 (77.0) 145 (81.5) 113 (63.5) 133 (74.7)
  1. aNo information available on tumor size in 12 cases; bmucinous, tubular or medullary; cno information available on tumor grade in 24 cases. DCC: dextran-coated charcoal; ICC: immunocytochemistry.